Indicators on LY 3000328 You Should Know
Other clinical trials in sufferers with non-Hodgkin's lymphoma [24] and sufferers with Highly developed malignancy [fourteen] have demonstrated also that zosuquidar did not drastically affect the pharmacokinetics of doxorubicin and experienced reasonable effects within the pharmacokinetics of vincristine. These clinical trials authorized that zosuq